Low Cost Alternative (LCA) and Reference Drug Program (RDP) Data Files
Last updated on December 5, 2024PharmaCare updates LCA and RDP information on the first Thursday of every month. PharmaCare can make changes mid-month, as needed, including generic drug pricing adjustments or expedited coverage for significant first-entry generics.
LCA data files
This list includes all new and existing generic drugs within the LCA Program with their current reimbursement limits (effective December 5, 2024).
RDP data files
This list includes all new and existing RDP drugs with their current reimbursement limits (effective December 5, 2024).
LCA/RDP Updates Workbook
The LCA/RDP Updates Workbook (effective December 5, 2024) includes four spreadsheets, with cumulative information on all new generic drug listings; all new LCA categories; all changes and effective dates for new LCA or RDP reimbursement limits; and any drug de-listings.
- Summary Spreadsheet—summarizes the most recent changes to the LCA/RDP
- LCA Updates Spreadsheet— all updates to the LCA Master Spreadsheet since April 1, 2024
- RDP Updates Spreadsheet— all updates to the RDP Master Spreadsheet since April 1, 2024
- Non-benefit Spreadsheet—all non-benefit generic drug listing decisions since April 1, 2024
How to interpret the data files
- LCA and RDP Data Dictionary (PDF, 142KB)—explanation of the data fields in the LCA and RDP data files
- LCA Pricing Exceptions—information on pricing exemptions for drugs available in multiple dosage forms and strengths
- List of Manufacturer Codes (PDF, 192 KB)—codes in the “MAN” field of the LCA and RDP data files
Policy
- Low Cost Alternative Program — Section 5.11, PharmaCare Policy Manual
- Reference Drug Program — Section 5.12, PharmaCare Policy Manual
If you have questions about the data files or historical pricing, please email PharmaCare.